Sugi Predict

Sugi Predict / Compounds / SCHEMBL3017005

SCHEMBL3017005

SCHEMBL3017005

[c]1c2ccccc2c2c3cccc4cccc(c5cccc1c52)c43

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ALDH1A1 P00352 8/20 0.46
▸ HSD17B10 Q99714 7/20 0.46
▸ CYP1A2 P05177 5/20 0.46
▸ HPGD P15428 5/20 0.46
▸ THRB P10828 1/20 0.46
▸ ERBB2 P04626 1/20 0.38
▸ FYN P06241 1/20 0.38
▸ MAOA P21397 1/20 0.38
▸ ACHE P22303 1/20 0.38
▸ AHR P35869 1/20 0.38
▸ TSHR P16473 6/20 0.34
▸ MAPK1 P28482 3/20 0.34
▸ L3MBTL1 Q9Y468 2/20 0.34
▸ CASP1 P29466 2/20 0.34
▸ HIF1A Q16665 2/20 0.34
▸ CYP3A4 P08684 2/20 0.33
▸ ATM Q13315 1/20 0.33
▸ CYP1A1 P04798 1/20 0.33
▸ CYP1B1 Q16678 1/20 0.33
▸ CYP2A6 P11509 3/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL55779 0.82 HSD17B10 (0.50) ALDH1A1HSD17B10CYP1A2HPGDTHRB
SCHEMBL7861352 0.79 CYP1A2 (0.40) ALDH1A1HSD17B10CYP1A2HPGDTHRB
SCHEMBL4501676 0.78 ALDH1A1 (0.63) ALDH1A1HSD17B10CYP1A2HPGDTHRB
SCHEMBL4856708 0.75 ALDH1A1 (0.62) ALDH1A1HSD17B10CYP1A2HPGDTHRB
SCHEMBL5477252 0.75 ALDH1A1 (0.60) ALDH1A1HSD17B10CYP1A2HPGDTHRB
SCHEMBL347568 0.75 ALDH1A1 (0.60) ALDH1A1HSD17B10CYP1A2HPGDTHRB
SCHEMBL5160967 0.74 ALDH1A1 (0.54) ALDH1A1HSD17B10CYP1A2HPGDTHRB
Triphenylene SCHEMBL28972585 0.72 ALDH1A1 (0.82) ALDH1A1HSD17B10CYP1A2HPGDTHRB
Triphenylene SCHEMBL5501206 0.72 ALDH1A1 (0.82) ALDH1A1HSD17B10CYP1A2HPGDTHRB
SCHEMBL29105767 0.72 ALDH1A1 (0.63) ALDH1A1HSD17B10CYP1A2HPGDTHRB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 141 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-111352300-A Hardmask composition, hardmask layer and method of forming pattern 三星SDI株式会社 2020-06-30 — — CN claimed
US-20200201185-A1 HARDMASK COMPOSITION, HARDMASK LAYER AND METHOD OF FORMING PATTERNS SAMSUNG SDI CO., LTD. (KR) 2020-06-25 — — US claimed
CN-108997347-B Fused ring compound and preparation method and application thereof 宁波卢米蓝新材料有限公司 2020-05-01 — — CN claimed
CN-108727398-B Fused ring compound and preparation method and application thereof 宁波卢米蓝新材料有限公司 2020-03-17 — — CN claimed
CN-106226997-B organic layer composition and method for forming pattern 三星SDI株式会社 2019-12-17 — — CN claimed
US-20190284334-A1 POLY (SPIROBIFLUORENE) AND ORGANIC ELECTROLUMINESCENT DEVICE CHANGCHUN INSTITUTE OF APPLIED CHEMISTRY CHINESE ACADEMY OF SCIENCES (CN) 2019-09-19 — — US claimed
EP-1731548-B1 Use of fluorescent polysiloxanes in chemical sensors for detection or dosage of nitrated compounds COMMISSARIAT ENERGIE ATOMIQUE (FR) 2009-03-11 — — EP claimed
CN-115028766-B Supported catalyst systems and methods of use thereof 埃克森美孚化学专利公司 2024-06-28 — — CN disclosed
CN-117539127-A Composition for forming resist underlayer film containing amide solvent 日产化学株式会社 2024-02-09 — — CN disclosed
WO-2023250518-A2 CATALYST FOR POLYMERIZATION OF CYCLIC ETHER AND CYCLIC ESTER MONOMERS AND THE RESULTING POLYMERS EXXONMOBIL CHEMICAL PATENTS INC. (US) 2023-12-28 — — WO disclosed
CN-110192152-B Composition for forming resist underlayer film containing amide solvent 日产化学株式会社 2023-11-03 — — CN disclosed
CN-110088149-B Supported catalyst systems and methods of use thereof 埃克森美孚化学专利公司 2023-10-27 — — CN disclosed
EP-2880097-B1 PROCESS TO PREPARE A VINYL TERMINATED POLYETHYLENE WITH LONG CHAIN BRANCHING EXXONMOBIL CHEMICAL PATENTS INC (US) 2023-10-18 — — EP disclosed
WO-2014022012-A1 VINYL TERMINATED POLYETHYLENE WITH LONG CHAIN BRANCHING EXXONMOBIL CHEMICAL PATENTS INC. (US) 2014-02-06 — — WO disclosed
US-20140039137-A1 Polyalphaolefins Prepared Using Modified Salan Catalyst Compounds EXXONMOBIL CHEMICAL PATENTS INC. 2014-02-06 — — US disclosed
US-20130260471-A1 USE OF CYCLIC AZABORONATES AS SENSITIVE MATERIALS IN SENSORS FOR DETECTING THE PRESENCE OF PEROXIDES IN A GASEOUS ENVIRONMENT COMMISSARIAT A L'ENERGIE ATOMIQUE ET AUX ENERGIES ALTERNATIVES (FR) 2013-10-03 — — US disclosed
US-20100181527-A1 NITROXIDE CONTAINING ELECTRODE MATERIALS FOR SECONDARY BATTERIES CIBA CORPORATION 2010-07-22 — — US disclosed
EP-2162937-A1 NITROXIDE CONTAINING ELECTRODE MATERIALS FOR SECONDARY BATTERIES BASF SE (DE) 2010-03-17 — — EP disclosed
WO-2008155247-A1 NITROXIDE CONTAINING ELECTRODE MATERIALS FOR SECONDARY BATTERIES BASF SE (CH) 2008-12-24 — — WO disclosed
JP-2001196180-A ORGANIC ELECTROLUMINESCENT ELEMENT NEC CORP 2001-07-19 — — JP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100181527-A1 NITROXIDE CONTAINING ELECTRODE MATERIALS FOR SECONDARY BATTERIES CAT, NQO1, NUCB2 ALDH1A1 1783/4885HSD17B10 2722/4885CYP1A2 273/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.